Triple-Negative Breast Cancer (TNBC) Available Phase Trials for Veliparib (DB07232)

Also known as: Triple-negative Breast Cancer

IndicationStatusPhase
DBCOND0067309 (Triple-Negative Breast Cancer (TNBC))AvailableNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02985658Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer